ResearcherXuzhou Medical CollegeActive in the last 2 years
Pengbo Zhang
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2023: 1 paper · 2024: 1 paper
Papers 2
- Correction: hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancr… Last author DOI 10.1186/s12943-024-01937-9↗
- hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal… Last author DOI 10.1186/s12943-023-01887-8↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yi Zhang · 2 shared papers, 2023–2024 · strength 0.35
- Paper Correction: hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and… DOI 10.1186/s12943-024-01937-9↗
- Paper hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gem… DOI 10.1186/s12943-023-01887-8↗
- Lei Xu · 2 shared papers, 2023–2024 · strength 0.35
- Paper Correction: hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and… DOI 10.1186/s12943-024-01937-9↗
- Paper hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gem… DOI 10.1186/s12943-023-01887-8↗
- Zeqiang Ren · 2 shared papers, 2023–2024 · strength 0.35
- Paper Correction: hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and… DOI 10.1186/s12943-024-01937-9↗
- Paper hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gem… DOI 10.1186/s12943-023-01887-8↗
- Xiao Ma · 1 shared paper, 2024 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.